V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010001 | 270016067 | 1.82 | 94 | Palliative (P) | 2015-12-16 | 2015-12-18 | BREVITY TRIAL | N | null | 270022312 | CHOP |
| 270010002 | 270005877 | 1.8 | 131 | null | 2017-06-23 | 2017-06-30 | null | N | N | 270022327 | CVP R |
| 270010003 | 270012904 | 1.49 | 63.6 | Curative (C) | 2015-10-20 | 2015-10-24 | ICE | 02 | N | 270022336 | CVP R |
| 270010004 | 270016068 | null | 61 | Palliative (P) | 2015-07-22 | 2015-08-17 | Brentuximab Vedotin | N | N | 270022337 | FCR |
| 270010005 | 270017868 | 1.78 | 69.3 | Palliative (P) | 2014-06-29 | 2014-06-30 | BENDAMUSTINE + RITUXIMAB | N | N | 270022338 | NOT MATCHED |
| 270010006 | 270017868 | 1.59 | 52 | Disease modification (D) | 2016-10-28 | 2016-11-05 | ECHELON 1 TRIAL | Y | N | 270022338 | CVP R |
| 270010007 | 270017868 | 1.74 | null | null | 2016-06-24 | 2016-06-26 | ESHAP | N | N | 270022338 | CVP R |
| 270010008 | 270019823 | 1.8 | 73 | null | 2016-10-30 | 2016-10-30 | CVP R | 02 | N | 270022356 | VINBLASTINE |
| 270010009 | 270005878 | 1.61 | 84.3 | Curative (C) | 2015-07-20 | 2015-07-27 | Bendamustine+Rituximab (1st Course) | N | N | 270022357 | ETOPOSIDE |
| 270010010 | 270012905 | null | null | null | 2015-04-16 | 2015-04-20 | CVP R | N | N | 270022380 | CISPLATIN + ETOPOSIDE |
| 270010011 | 270012905 | 1.57 | 63.25 | Disease modification (D) | 2016-03-20 | 2016-04-04 | GDP | 02 | Y | 270022380 | ABVD R |
| 270010012 | 270005879 | 1.85 | 71 | Curative (C) | 2015-01-24 | 2015-01-25 | IVE | 02 | null | 270022398 | COPP |
| 270010013 | 270005879 | 1.81 | 67.8 | Palliative (P) | 2014-09-28 | 2014-10-02 | Rituximab | 2 | Y | 270022398 | NOT MATCHED |
| 270010014 | 270005879 | 1.79 | null | Neo-adjuvant (N) | null | 2017-04-07 | CISPLATIN + CYTARABINE | null | null | 270022398 | CVP R |
| 270010015 | 270005879 | 1.75 | 77.2 | null | null | 2017-10-08 | null | 02 | N | 270022398 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010016 | 270005880 | 1.83 | 89.4 | Curative (C) | 2015-07-12 | 2015-07-17 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 270022431 | VINBLASTINE |
| 270010017 | 270005881 | 1.52 | 56 | Not known (9) | 2013-03-23 | 2013-03-23 | Brentuximab | N | N | 270022443 | CVP R |
| 270010018 | 270005882 | null | 83.6 | Curative (C) | 2017-11-06 | 2017-11-06 | CVP R | N | null | 270022458 | BRENTUXIMAB |
| 270010019 | 270005882 | 1.48 | 37 | Curative (C) | 2018-03-16 | 2018-04-16 | R ABVD | N | N | 270022458 | IVE |
| 270010020 | 270005883 | null | 69 | Palliative (P) | 2014-09-13 | 2014-09-16 | CVP R | N | N | 270022471 | RITUXIMAB |
| 270010021 | 270005884 | null | null | Curative (C) | 2016-10-01 | 2016-10-15 | null | 02 | N | 270022493 | CVP R |
| 270010022 | 270012908 | 1.59 | null | Curative (C) | 2017-12-03 | 2017-12-20 | DOXORUBICIN + ETOPOSIDE + VINCRISTINE | N | N | 270022506 | BREVITY TRIAL |
| 270010023 | 270012908 | null | 89.4 | Curative (C) | 2018-02-10 | 2018-02-19 | Vinblastine | N | N | 270022506 | RITUXIMAB |
| 270010024 | 270005885 | 1.57 | 39.3 | null | 2013-07-17 | 2013-07-18 | DHAP | 02 | N | 270022513 | CVP |
| 270010025 | 270005885 | 1.78 | 68 | null | 2016-10-20 | 2016-10-27 | Vinblastine | N | N | 270022513 | GEMCITABINE + PACLITAXEL |
| 270010026 | 270005886 | 1.72 | 101 | Curative (C) | 2017-10-26 | 2017-11-27 | Hydroxycarbamide | 02 | N | 270022529 | RITUXIMAB |
| 270010027 | 270005887 | 1.77 | null | Curative (C) | 2015-07-19 | 2015-07-19 | Rituximab | N | null | 270022530 | ESHAP |
| 270010028 | 270005887 | 1.5 | 0 | Palliative (P) | 2014-04-27 | 2014-04-28 | FLAG + Idarubicin | N | N | 270022530 | CVP R |
| 270010029 | 270005887 | 1.7 | 85.9 | Curative (C) | 2014-11-21 | 2014-11-21 | Brentuximab | N | Y | 270022530 | NOT MATCHED |
| 270010030 | 270005887 | null | null | null | 2014-03-13 | 2014-03-27 | Escalated BEACOP Dac | null | N | 270022530 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 270010031 | 270005888 | 1.64 | 86 | Disease modification (D) | 2014-09-28 | 2014-10-12 | BENDAMUSTINE + RITUXIMAB | N | N | 270022549 | CHOP |
| 270010032 | 270005889 | 1.52 | 105 | null | 2015-04-11 | 2015-04-22 | Rituximab | 02 | null | 270022550 | RITUXIMAB |
| 270010033 | 270005890 | 1.64 | 69.3 | Curative (C) | 2015-07-10 | 2015-07-15 | ECHELON 1 TRIAL | 2 | N | 270022551 | VINBLASTINE |
| 270010034 | 270005891 | 1.78 | 86.5 | Curative (C) | 2016-03-31 | 2016-04-06 | CISPLATIN + GEMCITABINE | 02 | Y | 270022553 | ETOPOSIDE |
| 270010036 | 270005893 | null | 84.2 | Palliative (P) | 2015-05-19 | 2015-06-06 | Etoposide oral | N | N | 270022558 | CHOP |
| 270010038 | 270005895 | 1.61 | 52.8 | Disease modification (D) | 2016-09-24 | 2016-09-24 | Etoposide oral | 02 | Y | 270022568 | BRENTUXIMAB |
| 270010039 | 270005896 | 1.65 | 56.3 | Curative (C) | 2013-02-13 | 2013-02-14 | ESHAP | 2 | N | 270022596 | CVP R |
| 270010040 | 270005897 | null | null | Curative (C) | null | 2018-03-05 | BEAM | null | null | 270022600 | GDP |
| 270010041 | 270005898 | 1.65 | 45.7 | Curative (C) | 2017-12-02 | 2017-12-19 | Mitomycin Intravesical | N | N | 270022603 | CVP R |
| 270010042 | 270005898 | 1.79 | null | Palliative (P) | 2013-07-15 | 2013-07-15 | Rituximab | 02 | N | 270022603 | CHOP |
| 270010043 | 270005899 | 1.63 | 76 | Disease modification (D) | 2016-02-08 | 2016-02-23 | Cetuximab 14 day | 2 | N | 270022623 | CHOP |
| 270010044 | 270005899 | 1.79 | 74.8 | Disease modification (D) | 2017-07-08 | 2017-08-01 | Rituximab | Y | N | 270022623 | CHOP |
| 270010045 | 270005900 | 1.74 | 75.4 | Palliative (P) | 2014-12-29 | 2015-01-02 | Vinblastine | 02 | N | 270022637 | ECHELON 1 TRIAL |
| 270010046 | 270005900 | 1.58 | 90.1 | Adjuvant (A) | 2014-09-28 | 2014-10-14 | CVP R | 02 | N | 270022637 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010047 | 270005901 | null | null | null | 2016-09-25 | 2016-10-12 | Vinblastine | 2 | N | 270022647 | GDCVP |
| 270010048 | 270005901 | null | 80 | Curative (C) | 2015-05-07 | 2015-05-08 | CHOP - 21 days | N | N | 270022647 | NOT MATCHED |
| 270010049 | 270005902 | 1.8 | 100 | Curative (C) | 2013-09-28 | 2014-12-25 | Imatinib 400mg | N | N | 270022660 | VINCRISTINE |
| 270010050 | 270005902 | 1.83 | 84 | null | null | 2014-03-10 | R ABVD | N | Y | 270022660 | NOT MATCHED |
| 270010051 | 270005902 | 1.6 | 68.1 | Curative (C) | 2013-03-20 | 2013-03-22 | HD Lymph Pred EuroNet-PHL-LP1 CVP | 02 | N | 270022660 | BENDAMUSTINE + RITUXIMAB |
| 270010052 | 270005903 | 0 | 100 | Disease modification (D) | 2016-07-23 | 2016-07-31 | CVP R | N | N | 270022673 | RITUXIMAB |